Shandong Lukang Record Pharmaceutical Co., Ltd. is a joint venture company of Shandong Lukang Pharmaceutical Co., Ltd. and Shanghai Record Pharmaceuticals Co., Ltd. Shandong Lukang Pharmaceutical Co., Ltd. is one of the three largest manufacturing bases of antibiotic raw material in China and the sole manufactory which owns 6APA銆?ACA銆?ADCA three antibiotic anlage product line. Record pharmaceuticals Co., Ltd has the predominance of R&D, production and international cooperation resources, and already built up the good cooperative relation with many business enterprises. Shanghai Record is a high-tech enterprise focuse in R&D and sale of the new medicine and its intermediates.

The cooperation of Shandong Lukang and Shanghai Record begins from November, 2003, the first synergic product is Aztreonam, this product has already gradually captured a local and international market now, also the quality gets the Euro-American customer's approbation and has a good develop foreground, and still be one of the mainly products of the joint venture company- Shandong Lukang Record Pharmaceutical Co., Ltd. Lukang Record succeeds to combine the predominance of Shandong Lukang and Shanghai Record. Our company has strong development potential in the technique, produce, sale, service etc. The company which favorably passes China GMP, ISO9000, ISO14001, has competitive production capability and owns strong technique of new product. Our company will focuse in researching and developing the new semi-synthesis antibiotics product and new series resins, manufacturing coenzyme Q10 and Ticarcillin Disodium. Our company will do more in research and development of the anticancer API and the very important intermediates of anti-AIDS API.